Table 3.
miR | Men [M (95% CI)] n = 11 | Women [M (95% CI)] n = 30 | p | q |
---|---|---|---|---|
miR-10b-5p | 0.156 (0.011–0.301) | 0.538 (0.064–1.012) | 0.123 | 0.263 |
miR-129-5p | 0.289 (−0.055 to 0.632) | 0.656 (0.361–0.950) | 0.095 | 0.263 |
miR-133a-5p | 0.000 (0.000–0.000) | 0.061 (−0.062 to 0.184) | 0.324 | 0.400 |
miR-141-3p | 46.671 (8.018–85.323) | 30.601 (19.490–41.712) | 0.398 | 0.440 |
miR-143-3p | 0.725 (−0.202 to 1.653) | 4.198 (−1.692 to 10.088) | 0.244 | 0.390 |
miR-145-5p | 0.011 (−0.002 to 0.024) | 0.094 (0.042–0.146) | 0.003 | 0.067 |
miR-150-3p | 0.310 (−0.085 to 0.706) | 0.595 (0.248–0.942) | 0.260 | 0.390 |
miR-15a-5p | 0.237 (−0.177 to 0.652) | 0.191 (0.052–0.331) | 0.822 | 0.822 |
miR-16-5p | 17.875 (3.201–38.95) | 35.814 (24.033–47.59) | 0.125 | 0.263 |
miR-146a-5p | 0.018 (−0.000 to 0.036) | 0.063 (0.021–0.105) | 0.048 | 0.216 |
miR-185-3p | 4.079 (−0.165 to 8.323) | 4.639 (2.751–6.526) | 0.797 | 0.822 |
miR-191-5p | 1.441 (−0.532 to 3.414) | 4.419 (2.734–6.104) | 0.021 | 0.216 |
miR-203a-5p | 0.000 (0.000–0.000) | 0.000 (0.000–0.000) | 0.215 | 0.376 |
miR-210-5p | 0.000 (0.000–0.000) | 0.000 (0.000–0.000) | 0.215 | 0.376 |
miR-211-5p | 0.000 (0.000–0.000) | 0.000 (0.000–0.000) | 0.306 | 0.400 |
miR-31-5p | 0.000 (0.000–0.000) | 0.001 (−0.001 to 0.003) | 0.305 | 0.400 |
miR-409-3p | 0.152 (−0.123 to 0.427) | 0.937 (0.120–1.754) | 0.070 | 0.244 |
miR-409-5p | 1.281 (−0.217 to 2.779) | 3.816 (1.766–5.866) | 0.043 | 0.216 |
miR-431-5p | 1.185 (0.145–2.225) | 2.537 (1.575–3.498) | 0.051 | 0.216 |
miR-488-3p | 0.236 (−0.249 to 0.721) | 0.041 (−0.014 to 0.097) | 0.398 | 0.440 |
miR-7g-5p | 0.901 (0.237–1.565) | 1.510 (1.066–1.954) | 0.116 | 0.263 |
M, mean; 95% CI, 95% confidence interval; miR, microRNA; CD, Cushing's disease; EAS, ectopic ACTH-syndrome.